NTIC
ELV icon

Napean Trading & Investment Company’s Elevance Health ELV Stock Holding History

Napean Trading & Investment Company’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-17,167
Closed -$6.68M – 36
2025
Q2 		$6.68M Buy
17,167
+3,643
+27% +$1.47M 1.77% 19
2025
Q1 		$5.88M Sell
13,524
-1,584
-10% -$636K 1.72% 20
2024
Q4 		$5.57M Buy
15,108
+6,247
+70% +$2.61M 1.38% 23
2024
Q3 		$4.61M Sell
8,861
-2,870
-24% -$1.53M 1.12% 31
2024
Q2 		$6.36M Hold
11,731
– – 1.51% 23
2024
Q1 		$6.08M Buy
11,731
+2,251
+24% +$1.12M 1.49% 26
2023
Q4 		$4.47M Buy
+9,480
New +$4.38M 1.21% 33

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Napean Trading & Investment Company's ELV Position: Q3 2025 in Review

Napean Trading & Investment Company sold out of Elevance Health (ELV) in Q3 2025, closing a stake of 17,167 shares — an estimated $6.68M sold.

Napean Trading & Investment Company first reported a position in ELV in Q4 2023 and held it in 7 quarters. The position peaked at $6.68M in Q2 2025. 1,511 funds tracked by Wall St. Rank hold ELV as of Q3 2025.

  • Napean Trading & Investment Company reported no remaining Elevance Health position as of Q3 2025 after selling out during the quarter.
  • Napean Trading & Investment Company sold 17,167 Elevance Health shares in Q3 2025, an estimated $6.68M.
  • Napean Trading & Investment Company first reported a position in Elevance Health in Q4 2023 and held it in 7 quarters.
  • Napean Trading & Investment Company's Elevance Health position peaked at $6.68M in Q2 2025.
  • 1,511 funds tracked by Wall St. Rank held Elevance Health as of Q3 2025.

Based on Napean Trading & Investment Company's 13F filing for Q3 2025, filed 10 Nov 2025.